Antagonizing TNFR1 (No decrease in mortality between placebo and p55-IgG in all infused patients; patients with severe sepsis who received p55-IgG, there was a trend toward reduced mortality at day 28). The gene discussed is TNFRSF1A; the disease is Sepsis.